Immediate Impact
2 hit
Citing Papers
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy
2025 Hit
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
2017 Hit
Works of Zhenqian Wu being referenced
The BET-Bromodomain Inhibitor JQ1 synergized ABT-263 against colorectal cancer cells through suppressing c-Myc-induced miR-1271-5p expression
2017
The chemokine CXCL9 expression is associated with better prognosis for colorectal carcinoma patients
2016